Wall Street Icon: “You must get on the right side of this thing”

I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.

This market shakeup is going to be much more intense.

Susan Alyson Wood net worth and biography

Susan Wood Biography and Net Worth

Director of iCAD

Dr. Susan Alyson Wood Ph.D. serves as Independent Director of the Company. She has served as the President and Chief Executive Officer of VIDA Diagnostics, Inc., a leader in precision imaging and AI for pulmonary medicine, since September 2009. From July 2005 to December 2008, she held the position of Executive Vice President of Marketing and Technology for Vital Images, Inc., an innovative software company specializing in cardiovascular applications for advanced analysis software. Dr. Wood holds multiple patents in the field of computer-aided detection and quantitative imaging; has authored numerous book chapters, peer-reviewed papers, abstracts, and has served as an invited speaker at numerous conferences in the area of three-dimensional imaging of the thorax, quantitative imaging and computer-aided detection. She holds a Bachelor of Science in Engineering from the University of Maryland, College Park and a Master of Science in Biomedical Engineering from Duke University. Dr. Wood also holds a Ph.D. from the Johns Hopkins Medical Institutions, School of Hygiene and Public Health.

How do I contact Susan Alyson Wood?: The corporate mailing address for Dr. Wood and other iCAD executives is 98 SPIT BROOK ROAD SUITE 100, NASHUA NH, 03062. iCAD can also be reached via phone at (603) 882-5200 and via email at [email protected]. Learn More on Susan Alyson Wood's contact information.
Has Susan Alyson Wood been buying or selling shares of iCAD?: Susan Alyson Wood has not been actively trading shares of iCAD within the last three months. Most recently, on Wednesday, December 8th, Susan Alyson Wood bought 1,500 shares of iCAD stock. The stock was acquired at an average cost of $7.31 per share, with a total value of $10,965.00. Learn More on Susan Alyson Wood's trading history.
Who are iCAD's active insiders?: iCAD's insider roster includes Charles Carter (CFO), Jonathan Go (CTO), Timothy Irish (Director), Michael Klein (CEO), Andy Sassine (Director), Stacey Stevens (President), and Susan Wood (Director). Learn More on iCAD's active insiders.

Susan Alyson Wood Insider Trading History at iCAD

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/8/2021	Buy	1,500	$7.31	$10,965.00

Susan Alyson Wood Buying and Selling Activity at iCAD

iCAD Company Overview

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Today's Range

Now: $1.83

$1.73

$1.84

50 Day Range

MA: $1.81

$1.52

$2.40

2 Week Range

Now: $1.83

$1.18

$2.65

Volume

196,293 shs

Average Volume

187,851 shs

Market Capitalization

$48.57 million

P/E Ratio

N/A

Dividend Yield